0001950047-26-003775.txt : 20260427 0001950047-26-003775.hdr.sgml : 20260427 20260427163246 ACCESSION NUMBER: 0001950047-26-003775 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MapLight Therapeutics, Inc. CENTRAL INDEX KEY: 0001770069 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 832163243 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-42914 FILM NUMBER: 26901513 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-839-4360 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Alvarado Therapeutics, Inc. DATE OF NAME CHANGE: 20190307 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: GILLIS JONATHAN CENTRAL INDEX KEY: 0001709954 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O MAPLIGHT THERAPEUTICS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 144 1 primary_doc.xml 144 0001709954 XXXXXXXX LIVE 0001770069 MapLight Therapeutics, Inc. 001-42914 800 Chesapeake Drive Redwood City CA 94063 6179846300 JONATHAN GILLIS Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

69835 2078289.60 42436326 04/27/2026 NASDAQ Common 07/05/2024 Restricted Stock Units Issuer N 48481 07/05/2024 N/A Common 08/19/2019 Restricted vesting of Pre IPO shares Issuer N 21354 08/19/2019 N/A N JONATHAN GILLIS

800 Chesapeake Drive Redwood City CA 94063

Common 04/15/2026 3590 95529.90 The securities to be sold were acquired upon the vesting of restricted stock units during the period of 07/05/2024 through 04/01/2026. 04/27/2026 12/26/2025 /s/ Jonathan Gillis